Positive News Coverage Somewhat Unlikely to Impact Allscripts Healthcare Solutions (MDRX) Stock Price

News coverage about Allscripts Healthcare Solutions (NASDAQ:MDRX) has trended positive this week, according to Accern. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave headlines about the software maker an impact score of 45.9119074114253 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the headlines that may have effected Accern Sentiment’s analysis:

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at $14.40 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. The firm has a market cap of $2,550.00, a P/E ratio of 32.53, a P/E/G ratio of 2.49 and a beta of 1.34. Allscripts Healthcare Solutions has a twelve month low of $10.19 and a twelve month high of $14.51.

MDRX has been the topic of a number of recent research reports. Maxim Group restated a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, November 3rd. Zacks Investment Research cut shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, November 8th. Robert W. Baird upped their price target on shares of Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a research note on Friday, November 3rd. Jefferies Group set a $17.00 price target on shares of Allscripts Healthcare Solutions and gave the company a “buy” rating in a research note on Friday, August 25th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $17.00 price target on shares of Allscripts Healthcare Solutions in a research note on Wednesday, September 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and eleven have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $15.06.

In other news, SVP James Hewitt sold 36,796 shares of the stock in a transaction on Friday, December 1st. The shares were sold at an average price of $14.11, for a total value of $519,191.56. Following the transaction, the senior vice president now owns 181,766 shares of the company’s stock, valued at approximately $2,564,718.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, President Richard J. Poulton sold 15,000 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $13.56, for a total transaction of $203,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 71,796 shares of company stock worth $992,992 in the last ninety days. 0.75% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://ledgergazette.com/2017/12/09/positive-news-coverage-somewhat-unlikely-to-impact-allscripts-healthcare-solutions-mdrx-stock-price.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply